These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 14974825

  • 21. Gingival enlargement in children administered cyclosporine after liver transplantation.
    Lin YT, Yang FT.
    J Periodontol; 2010 Sep; 81(9):1250-5. PubMed ID: 20397903
    [Abstract] [Full Text] [Related]

  • 22. Transforming growth factor-beta1 gene expression and cyclosporine A-induced gingival overgrowth: a pilot study.
    Radwan-Oczko M, Boratyńska M, Zietek M, Dobosz T.
    J Clin Periodontol; 2008 May; 35(5):371-8. PubMed ID: 18355347
    [Abstract] [Full Text] [Related]

  • 23. Non-surgical periodontal treatment of cyclosporin A-induced gingival overgrowth: immunohistochemical results.
    Aimetti M, Romano F, Marsico A, Navone R.
    Oral Dis; 2008 Apr; 14(3):244-50. PubMed ID: 18266838
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. SPARC gene polymorphism in renal transplant patients with gingival overgrowth.
    Drozdzik A, Kurzawski M, Kozak M, Banach J, Drozdzik M.
    J Periodontol; 2007 Nov; 78(11):2185-9. PubMed ID: 17970686
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Two-year experience with tacrolimus in renal transplantation after late conversion from cyclosporine therapy.
    Videla CO.
    Transplant Proc; 2009 Nov; 41(6):2659-63. PubMed ID: 19715995
    [Abstract] [Full Text] [Related]

  • 28. Non-surgical periodontal therapy of cyclosporin A gingival overgrowth in organ transplant patients. Clinical results at 12 months.
    Aimetti M, Romano F, Priotto P, Debernardi C.
    Minerva Stomatol; 2005 May; 54(5):311-9. PubMed ID: 15985985
    [Abstract] [Full Text] [Related]

  • 29. Prevalence, severity, and risk variables associated with gingival overgrowth in renal transplant subjects treated under tacrolimus or cyclosporin regimens.
    de Oliveira Costa F, Diniz Ferreira S, de Miranda Cota LO, da Costa JE, Aguiar MA.
    J Periodontol; 2006 Jun; 77(6):969-75. PubMed ID: 16734570
    [Abstract] [Full Text] [Related]

  • 30. Gingival overgrowth in subjects under immunosuppressive regimens based on cyclosporine, tacrolimus, or sirolimus.
    Cota LO, Aquino DR, Franco GC, Cortelli JR, Cortelli SC, Costa FO.
    J Clin Periodontol; 2010 Oct; 37(10):894-902. PubMed ID: 20618547
    [Abstract] [Full Text] [Related]

  • 31. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P, Lilly L, Scudamore C, Erb S, Yoshida E, Kneteman N, Bain V, Ghent C, Marotta P, Grant D, Wall W, Tchervenkov J, Barkun J, Roy A, Marleau D, McAlister V, Peltekian K.
    Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400
    [Abstract] [Full Text] [Related]

  • 32. Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation.
    Iaria G, Pisani F, De Luca L, Sforza D, Manuelli M, Perrone L, Bellini I, Angelico R, Tisone G.
    Transplant Proc; 2010 May; 42(4):1169-70. PubMed ID: 20534252
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of tacrolimus versus cyclosporine microemulsion in primary cardiac transplant recipients: 6-month results in Taiwan.
    Wang CH, Ko WJ, Chou NK, Wang SS.
    Transplant Proc; 2004 Oct; 36(8):2384-5. PubMed ID: 15561256
    [Abstract] [Full Text] [Related]

  • 34. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 35. Early conversion from cyclosporine to tacrolimus increases renal graft function in chronic allograft nephropathy at BANFF stages I and II.
    Marcard T, Ivens K, Grabensee B, Willers R, Helmchen U, Rump LC, Blume C.
    Transpl Int; 2008 Dec; 21(12):1153-62. PubMed ID: 18684111
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
    Barone GW, Ketel BL, Abul-Ezz SR, Lightfoot ML.
    JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766
    [Abstract] [Full Text] [Related]

  • 38. Periodontal changes in liver cirrhosis and post-transplantation patients. I: clinical findings.
    Oettinger-Barak O, Barak S, Machtei EE, Ardekian L, Baruch Y, Peled M.
    J Periodontol; 2001 Sep; 72(9):1236-40. PubMed ID: 11577956
    [Abstract] [Full Text] [Related]

  • 39. Tacrolimus is not associated with gingival overgrowth in renal transplant patients.
    James JA, Jamal S, Hull PS, Macfarlane TV, Campbell BA, Johnson RW, Short CD.
    J Clin Periodontol; 2001 Sep; 28(9):848-52. PubMed ID: 11493354
    [Abstract] [Full Text] [Related]

  • 40. Prevalence of gingival overgrowth in transplant patients immunosuppressed with tacrolimus.
    Ellis JS, Seymour RA, Taylor JJ, Thomason JM.
    J Clin Periodontol; 2004 Feb; 31(2):126-31. PubMed ID: 15016038
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.